Interestingly, interactions of KIRs with their specific ligands have a profound impact on CD8+ T cell expression profiles, involving multiple signaling pathways, effector functions, the secretome, and consequently, the cellular microenvironment, which could impact their cancer immunosurveillance capacities. Here, CD8A is linked to cancer.